XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues:        
Base rental - UHS facilities $ 4,066 $ 4,019 $ 12,226 $ 11,916
Base rental - Non-related parties 9,273 8,763 27,118 26,438
Bonus rental - UHS facilities 1,118 1,085 3,557 3,453
Tenant reimbursements and other - Non-related parties 2,168 1,620 5,984 5,523
Tenant reimbursements and other - UHS facilities 176 199 603 607
Revenues, Total 16,801 15,686 49,488 47,937
Expenses:        
Depreciation and amortization 5,893 5,424 16,872 16,817
Advisory fees to UHS 832 708 2,380 2,067
Other operating expenses 4,663 4,461 13,603 13,921
Transaction costs 331   477 204
Costs and Expenses, Total 11,719 10,593 33,332 33,009
Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gain 5,082 5,093 16,156 14,928
Equity in income of unconsolidated LLCs [1] 1,110 561 3,396 1,826
Gain on property exchange       8,742
Interest expense, net (2,374) (2,015) (6,783) (6,157)
Net income $ 3,818 $ 3,639 $ 12,769 $ 19,339
Basic earnings per share $ 0.28 $ 0.27 $ 0.95 $ 1.46
Diluted earnings per share $ 0.28 $ 0.27 $ 0.95 $ 1.45
Weighted average number of shares outstanding - Basic 13,575 13,298 13,426 13,289
Weighted average number of share equivalents   4 5 8
Weighted average number of shares and equivalents outstanding - Diluted 13,575 13,302 13,431 13,297
[1] Our share of net income for the three and nine months ended September 30, 2016 includes approximately $291,000 and $880,000, respectively, of interest income earned by us on an advance made to Arlington Medical Properties, LLC (advance balance payable to us is approximately $21.8 million as of September 30, 2016). There were no advances outstanding during the first nine months of 2015, therefore there was no interest income earned by us for the three and nine months ended September 30, 2015. Also, as mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% previously.